4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-008023
Chief Development Officer sold 20,000 shares at $35.18 ($703,656)
- Chief Development Officer acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Guyer William · Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $21.65 | $433,000 | 21,235 | D |
| 2026-01-06 | Sale : show line 2 in the form 10b5-1 | −20,000 | $35.18 | $703,656 | 1,235 | D |
| Open-market sales · 20,000 sh · avg $35.18 · $703,656 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-06 | Exercise or conversion : show line 3 in the form 10b5-1 Stock option (right to buy) | −20,000 | 250,000 | D |
Loading xslF345X05/ownership.xml…